Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.

[1]  J. Tward,et al.  Overall and cause‐specific survival for patients undergoing lobectomy, near‐total, or total thyroidectomy for differentiated thyroid cancer , 2011, Head & neck.

[2]  S. Lam,et al.  Disease control of differentiated thyroid carcinomas by hemithyroidectomy. , 2010, Singapore medical journal.

[3]  M. Hassanain,et al.  Conservative management of well-differentiated thyroid cancer. , 2010, Canadian journal of surgery. Journal canadien de chirurgie.

[4]  I. Ganly,et al.  Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. , 2010, Thyroid : official journal of the American Thyroid Association.

[5]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[6]  Amy Y. Chen,et al.  Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005 , 2009, Cancer.

[7]  S. Devesa,et al.  Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005 , 2009, Cancer Epidemiology Biomarkers & Prevention.

[8]  B. Heniford,et al.  Short-Term Outcomes after Unilateral versus Complete Thyroidectomy for Malignancy: A National Perspective , 2009, The American surgeon.

[9]  C. Ko,et al.  Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.

[10]  W. Wiersinga,et al.  European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. , 2006, European journal of endocrinology.

[11]  P. Bernante,et al.  Complications of Thyroid Surgery: Analysis of a Multicentric Study on 14,934 Patients Operated on in Italy over 5 Years , 2004, World Journal of Surgery.

[12]  A. Oberg,et al.  Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients , 2002, World Journal of Surgery.

[13]  B. Cady,et al.  Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. , 1998, Archives of surgery.

[14]  P. Yeo,et al.  Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. , 1997, The Journal of clinical endocrinology and metabolism.

[15]  J. Shah,et al.  Intermediate-risk group for differentiated carcinoma of thyroid. , 1994, Surgery.

[16]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[17]  E. Strong,et al.  Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. , 1993, American journal of surgery.

[18]  M. Kaplan,et al.  Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. , 1990, Endocrinology and metabolism clinics of North America.

[19]  O. Clark,et al.  Thyroid cancer: the case for total thyroidectomy. , 1988, European journal of cancer & clinical oncology.

[20]  W. Taylor,et al.  Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. , 1987, Surgery.

[21]  E. Mazzaferri.  Increasing Incidence of Thyroid Cancer in the United States, 1973–2002Davies L, Welch HG (Dept of Veterans Affairs Med Ctr, White River Junction, Vt; Darmouth Med School, Hanover, NH) JAMA 295:2164–2167, 2006§ , 2007 .

[22]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[23]  L. Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.